EW Edwards Lifesciences Corp
- Stocks
- Healthcare
- NYSE: EW
Price (delayed)
$76.93
Market cap
$45.17B
P/E Ratio
11.01
Dividend/share
N/A
EPS
$6.99
Enterprise value
$42.6B
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of
Highlights
The company's EPS has surged by 188% YoY
The net income has soared by 182% YoY
The price to earnings (P/E) is 70% lower than the 5-year quarterly average of 37.6 but 8% higher than the last 4 quarters average of 10.4
Key stats
What are the main financial stats of EW
Market
Valuations
Earnings
Shares outstanding
587.1M
Market cap
$45.17B
Enterprise value
$42.6B
Price to earnings (P/E)
11.01
Price to book (P/B)
4.28
Price to sales (P/S)
7.94
EV/EBIT
9.71
EV/EBITDA
9.33
EV/Sales
7.49
Revenue
$5.69B
Gross profit
$4.48B
Operating income
$1.42B
Net income
$4.15B
EBIT
$4.39B
EBITDA
$4.56B
Free cash flow
$587.9M
Per share
Balance sheet
Liquidity
EPS
$6.99
EPS diluted
$6.98
Free cash flow per share
$1
Book value per share
$17.98
Revenue per share
$9.69
TBVPS
$17.95
Total assets
$13.49B
Total liabilities
$2.88B
Debt
$702.6M
Equity
$10.55B
Working capital
$5.17B
Debt to equity
0.07
Current ratio
4.68
Quick ratio
3.53
Net debt/EBITDA
-0.56
Margins
Efficiency
Dividend
EBITDA margin
80.3%
Gross margin
78.9%
Net margin
73%
Operating margin
25%
Return on assets
31.6%
Return on equity
41.3%
Return on invested capital
71.5%
Return on capital employed
36.3%
Return on sales
77.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
EW stock price
How has the Edwards Lifesciences stock price performed over time
Intraday
-1.57%
1 week
-2.92%
1 month
-1.43%
1 year
17.38%
YTD
3.92%
QTD
-1.64%
Financial performance
How have Edwards Lifesciences's revenue and profit performed over time
Revenue
$5.69B
Gross profit
$4.48B
Operating income
$1.42B
Net income
$4.15B
Gross margin
78.9%
Net margin
73%
The net income has soared by 182% YoY
The net margin has soared by 158% YoY but it has contracted by 3.6% from the previous quarter
EW's revenue is up by 9% year-on-year and by 2.9% since the previous quarter
The company's operating margin fell by 9% YoY and by 3.1% QoQ
Price vs fundamentals
How does EW's price correlate with its fundamentals
Growth
What is Edwards Lifesciences's growth rate over time
Valuation
What is Edwards Lifesciences stock price valuation
P/E
11.01
P/B
4.28
P/S
7.94
EV/EBIT
9.71
EV/EBITDA
9.33
EV/Sales
7.49
The company's EPS has surged by 188% YoY
The price to earnings (P/E) is 70% lower than the 5-year quarterly average of 37.6 but 8% higher than the last 4 quarters average of 10.4
The stock's price to book (P/B) is 51% less than its 5-year quarterly average of 8.8
The equity has grown by 42% year-on-year and by 4.1% since the previous quarter
The P/S is 26% below the 5-year quarterly average of 10.9 but 3.5% above the last 4 quarters average of 7.8
EW's revenue is up by 9% year-on-year and by 2.9% since the previous quarter
Efficiency
How efficient is Edwards Lifesciences business performance
The company's return on invested capital has surged by 168% YoY
The company's return on sales has surged by 144% YoY but it fell by 2.6% QoQ
EW's return on assets has surged by 107% year-on-year but it is down by 7% since the previous quarter
Edwards Lifesciences's return on equity has surged by 96% YoY but it has decreased by 8% QoQ
Dividends
What is EW's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for EW.
Financial health
How did Edwards Lifesciences financials performed over time
EW's quick ratio has surged by 52% year-on-year and by 6% since the previous quarter
The total assets is up by 34% year-on-year and by 3.6% since the previous quarter
The debt is 93% less than the equity
The equity has grown by 42% year-on-year and by 4.1% since the previous quarter
The company's debt to equity fell by 22% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.